# Humacyte, Inc.: Form 8-K, filed Sep 22, 2020

- Company: [Humacyte, Inc.](/companies/huma.md) (CIK 1818382)
- Form: 8-K
- Filed: 2020-09-22
- Accepted by EDGAR: Sep 22, 2020, 17:10 ET
- Period: 2020-09-17
- Accession: 0001213900-20-027850
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1818382/000121390020027850/ea127151-8k_alphahealth.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818382/000121390020027850/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818382/000121390020027850/ea127151-8k_alphahealth.htm

Filed Sep 22, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-027850. Last ingested by Listed: Nov 11, 2026, 01:52 ET. No prices; not investment advice.
